SCHEMBL118349

SCHEMBL118349

O=[C]NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1539042 0.59
SCHEMBL10486493 0.58
SCHEMBL1459286 0.56
SCHEMBL6349880 0.56
SCHEMBL1963922 0.56
SCHEMBL11136608 0.56
SCHEMBL1140009 0.56
SCHEMBL3156856 0.56
SCHEMBL5670 0.56
SCHEMBL620133 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5476 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115466251-B Condensed heterocyclic compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-06-21 CN claimed
WO-2024086296-A1 COMPOUNDS USEFUL IN MODULATING EGFR AND PI3K MEKANISTIC THERAPEUTICS LLC (US) 2024-04-25 WO claimed
EP-3466934-B1 SULFONAMIDE COMPOUNDS OR SALT THEREOF AS RIBONUCLEOTIDE REDUCTASE INHIBITORS FOR TREATING CANCER TAIHO PHARMACEUTICAL CO LTD (JP) 2024-03-27 EP claimed
US-20240009169-A9 PPARG Modulators for the Treatment of Osteoporosis UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2024-01-11 US claimed
US-20230348516-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE S.A. (PL) 2023-11-02 US claimed
EP-4269400-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS Molecure SA (PL) 2023-11-01 EP claimed
WO-2023171608-A1 METHOD FOR PRODUCING POLYOXYETHYLENE DERIVATIVE, METHOD FOR QUANTITATING POLYOXYETHYLENE COMPOUND, AND LABELING REAGENT FOR ANALYSIS USE 日油株式会社 2023-09-14 WO claimed
WO-2023161316-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-31 WO claimed
WO-2023138674-A1 N-HYDROXYQUINOLINE CARBOXAMIDE COMPOUND AND USE THEREOF 默达药物(香港)有限公司 2023-07-27 WO claimed
WO-2023138675-A1 QUINOLINE COMPOUND AND USE THEREOF 默达药物(香港)有限公司 2023-07-27 WO claimed
EP-0050326-A2 Benzo(b)thiophenes HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1982-04-28 EP claimed
EP-0042154-A1 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-23 EP claimed
EP-0042100-A1 Pyrazolopyridazine derivatives, intermediates and processes for their preparation, and medicaments containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-12-23 EP claimed
US-4307094-A ANTIHYPERTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1981-12-22 US claimed
EP-0007319-B1 INDAN-1-CARBOXYLIC ACID DERIVATIVES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS SCHERING AKTIENGESELLSCHAFT (DE) 1981-09-16 EP claimed
EP-0024309-A2 Triazolopyridazine derivatives, process and intermediates for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-03-04 EP claimed
EP-0013666-A1 Phenanthroline derivatives, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1980-07-23 EP claimed
US-4056624-A SUBSTITUTED BENZINDOLE AMERICAN HOECHST CORPORATION (US) 1977-11-01 US claimed
US-4013719-A ANTILIPEMIC, ANTIALLERGEN CIBA-GEIGY CORPORATION (US) 1977-03-22 US claimed
US-3931407-A ANTIINFLAMMATORY, ANALGESIC AMERICAN HOECHST CORPORATION (US) 1976-01-06 US claimed